| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 7.71e-07 | 8 | 49 | 3 | GO:0098882 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.49e-04 | 42 | 49 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 4.52e-04 | 13 | 49 | 2 | GO:0140410 | |
| GeneOntologyBiologicalProcess | RNA splicing | 2.18e-05 | 502 | 49 | 8 | GO:0008380 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 8.24e-05 | 6 | 49 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 1.15e-04 | 7 | 49 | 2 | GO:0150037 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 1.26e-04 | 41 | 49 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.95e-04 | 358 | 49 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.95e-04 | 358 | 49 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.07e-04 | 362 | 49 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | skin development | 2.44e-04 | 373 | 49 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 2.46e-04 | 10 | 49 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 2.88e-04 | 246 | 49 | 5 | GO:0045216 | |
| GeneOntologyBiologicalProcess | mRNA processing | 3.03e-04 | 551 | 49 | 7 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 3.73e-04 | 59 | 49 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 4.24e-04 | 13 | 49 | 2 | GO:0031632 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 4.24e-04 | 13 | 49 | 2 | GO:1901634 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 4.24e-04 | 13 | 49 | 2 | GO:0099502 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 6.31e-07 | 8 | 48 | 3 | GO:0048788 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 4.06e-06 | 14 | 48 | 3 | GO:0099569 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.95e-05 | 23 | 48 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | tricellular tight junction | 3.09e-05 | 4 | 48 | 2 | GO:0061689 | |
| GeneOntologyCellularComponent | keratohyalin granule | 5.14e-05 | 5 | 48 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | nuclear speck | 5.35e-05 | 431 | 48 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | cell cortex region | 1.51e-04 | 45 | 48 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | nuclear body | 9.55e-04 | 903 | 48 | 8 | GO:0016604 | |
| HumanPheno | Cervical C2/C3 vertebral fusion | 1.95e-05 | 13 | 22 | 3 | HP:0004602 | |
| Domain | Filaggrin | 6.47e-06 | 2 | 48 | 2 | IPR003303 | |
| Domain | Znf_FYVE_PHD | 5.48e-04 | 147 | 48 | 4 | IPR011011 | |
| Domain | S100_CABP | 2.18e-03 | 27 | 48 | 2 | PS00303 | |
| Domain | S_100 | 2.18e-03 | 27 | 48 | 2 | PF01023 | |
| Domain | S100_Ca-bd_sub | 2.34e-03 | 28 | 48 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 2.34e-03 | 28 | 48 | 2 | IPR001751 | |
| Domain | S_100 | 2.34e-03 | 28 | 48 | 2 | SM01394 | |
| Domain | LDLR_class-A_CS | 4.74e-03 | 40 | 48 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 5.97e-03 | 45 | 48 | 2 | PF00057 | |
| Domain | - | 6.23e-03 | 46 | 48 | 2 | 4.10.400.10 | |
| Domain | ZnF_C3H1 | 6.77e-03 | 48 | 48 | 2 | SM00356 | |
| Domain | LDLRA_1 | 6.77e-03 | 48 | 48 | 2 | PS01209 | |
| Domain | zf-CCCH | 7.04e-03 | 49 | 48 | 2 | PF00642 | |
| Domain | LDrepeatLR_classA_rpt | 7.04e-03 | 49 | 48 | 2 | IPR002172 | |
| Domain | LDLa | 7.04e-03 | 49 | 48 | 2 | SM00192 | |
| Domain | LDLRA_2 | 7.04e-03 | 49 | 48 | 2 | PS50068 | |
| Domain | Znf_CCCH | 9.76e-03 | 58 | 48 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 9.76e-03 | 58 | 48 | 2 | PS50103 | |
| Domain | EF_Hand_1_Ca_BS | 1.03e-02 | 175 | 48 | 3 | IPR018247 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.39e-02 | 775 | 48 | 6 | PS50157 | |
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 19812333 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 14734538 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24212375 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28767685 | ||
| Pubmed | LSR defines cell corners for tricellular tight junction formation in epithelial cells. | 1.94e-06 | 2 | 49 | 2 | 21245199 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22933801 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 34132262 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24813994 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZSCAN29 FLG TCF20 DROSHA ZC3H13 DDX42 PRPF38A FLG2 NSRP1 AFF4 | 2.22e-06 | 1082 | 49 | 10 | 38697112 |
| Pubmed | TEX2 ZC3H13 CCNL1 DDX42 ASH1L DYRK1A PRPF38A TNFAIP3 REPIN1 AFF4 | 2.26e-06 | 1084 | 49 | 10 | 11544199 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 5.68e-06 | 1203 | 49 | 10 | 29180619 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24012418 | ||
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 5.83e-06 | 3 | 49 | 2 | 23403047 | |
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 5.83e-06 | 3 | 49 | 2 | 28928464 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15728193 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 12163476 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 32437351 | ||
| Pubmed | 1.15e-05 | 31 | 49 | 3 | 15217342 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 12391317 | ||
| Pubmed | Fusion Competent Synaptic Vesicles Persist upon Active Zone Disruption and Loss of Vesicle Docking. | 1.16e-05 | 4 | 49 | 2 | 27537483 | |
| Pubmed | Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing. | 1.16e-05 | 4 | 49 | 2 | 26024086 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 23239027 | ||
| Pubmed | ELKS1 Captures Rab6-Marked Vesicular Cargo in Presynaptic Nerve Terminals. | 1.94e-05 | 5 | 49 | 2 | 32521280 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 27304082 | ||
| Pubmed | LSR DROSHA MRM1 CCNL1 DYRK1A CHD1 PRPF38A REPIN1 USP6NL AFF4 | 3.75e-05 | 1497 | 49 | 10 | 31527615 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 16924111 | ||
| Pubmed | Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites. | 4.07e-05 | 7 | 49 | 2 | 29398114 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 4.07e-05 | 7 | 49 | 2 | 35176221 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 4.07e-05 | 7 | 49 | 2 | 36398873 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 24889144 | ||
| Pubmed | 6.38e-05 | 152 | 49 | 4 | 16009940 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 14623875 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 21144999 | ||
| Pubmed | The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. | 1.50e-04 | 13 | 49 | 2 | 19081073 | |
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 21228161 | ||
| Pubmed | 1.93e-04 | 601 | 49 | 6 | 33658012 | ||
| Pubmed | No replication of genetic association between candidate polymorphisms and Alzheimer's disease. | 2.30e-04 | 16 | 49 | 2 | 19889475 | |
| Pubmed | Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. | 2.93e-04 | 18 | 49 | 2 | 19047128 | |
| Pubmed | Analyses of associations with asthma in four asthma population samples from Canada and Australia. | 3.02e-04 | 92 | 49 | 3 | 19247692 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.60e-04 | 954 | 49 | 7 | 36373674 | |
| Pubmed | 3.64e-04 | 20 | 49 | 2 | 23791195 | ||
| Pubmed | 3.80e-04 | 963 | 49 | 7 | 28671696 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 4.01e-04 | 21 | 49 | 2 | 19601998 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 4.23e-04 | 450 | 49 | 5 | 16751776 | |
| Pubmed | Rap1 controls epiblast morphogenesis in sync with the pluripotency states transition. | 4.83e-04 | 23 | 49 | 2 | 35998584 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 6.18e-04 | 26 | 49 | 2 | 17124501 | |
| Pubmed | 6.67e-04 | 27 | 49 | 2 | 26544073 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.38e-04 | 774 | 49 | 6 | 15302935 | |
| Pubmed | 7.93e-04 | 128 | 49 | 3 | 30995482 | ||
| Pubmed | Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. | 8.25e-04 | 30 | 49 | 2 | 12522270 | |
| Pubmed | 8.48e-04 | 131 | 49 | 3 | 28634551 | ||
| Pubmed | 9.22e-04 | 808 | 49 | 6 | 20412781 | ||
| Pubmed | 1.04e-03 | 1487 | 49 | 8 | 33957083 | ||
| Pubmed | 1.25e-03 | 37 | 49 | 2 | 32201365 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.28e-03 | 861 | 49 | 6 | 36931259 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.36e-03 | 341 | 49 | 4 | 32971831 | |
| Interaction | FAM76A interactions | 1.65e-07 | 21 | 48 | 4 | int:FAM76A | |
| Interaction | DHX8 interactions | 4.03e-07 | 292 | 48 | 8 | int:DHX8 | |
| Interaction | PRPF38A interactions | 3.97e-05 | 161 | 48 | 5 | int:PRPF38A | |
| Interaction | BSN interactions | 7.87e-05 | 35 | 48 | 3 | int:BSN | |
| Interaction | C1orf35 interactions | 8.08e-05 | 304 | 48 | 6 | int:C1orf35 | |
| Interaction | GAGE2E interactions | 8.57e-05 | 36 | 48 | 3 | int:GAGE2E | |
| Interaction | RIMS1 interactions | 1.18e-04 | 40 | 48 | 3 | int:RIMS1 | |
| Interaction | ERC2 interactions | 1.36e-04 | 42 | 48 | 3 | int:ERC2 | |
| Cytoband | 17q23.3 | 4.55e-06 | 30 | 49 | 3 | 17q23.3 | |
| Cytoband | 19q13.12 | 6.47e-05 | 72 | 49 | 3 | 19q13.12 | |
| Cytoband | 1q21.3 | 2.73e-04 | 117 | 49 | 3 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 2.94e-04 | 120 | 49 | 3 | chr17q23 | |
| Cytoband | 16q21 | 1.07e-03 | 45 | 49 | 2 | 16q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q21 | 3.26e-03 | 79 | 49 | 2 | chr16q21 | |
| Cytoband | 5q31 | 6.77e-03 | 115 | 49 | 2 | 5q31 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 6.34e-05 | 7 | 32 | 2 | 1350 | |
| GeneFamily | EF-hand domain containing | 6.71e-03 | 219 | 32 | 3 | 863 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.05e-03 | 718 | 32 | 5 | 28 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.92e-08 | 188 | 49 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.54e-08 | 200 | 49 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.20e-06 | 192 | 49 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 155 | 49 | 4 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.61e-05 | 156 | 49 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-05 | 159 | 49 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.73e-05 | 171 | 49 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 173 | 49 | 4 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.66e-05 | 181 | 49 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 182 | 49 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.86e-05 | 183 | 49 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.18e-05 | 186 | 49 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.74e-05 | 191 | 49 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.74e-05 | 191 | 49 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.98e-05 | 193 | 49 | 4 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.47e-05 | 197 | 49 | 4 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 6.47e-05 | 197 | 49 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.47e-05 | 197 | 49 | 4 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.60e-05 | 198 | 49 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-05 | 198 | 49 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 199 | 49 | 4 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 199 | 49 | 4 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 199 | 49 | 4 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.86e-05 | 200 | 49 | 4 | 061ba851f941c616ddb462512e826c412881c3ce | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.17e-07 | 152 | 45 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Lung diseases | 2.33e-04 | 78 | 45 | 3 | C0024115 | |
| Disease | Alzheimer disease, polygenic risk score | 2.52e-04 | 586 | 45 | 6 | EFO_0030082, MONDO_0004975 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.43e-04 | 18 | 45 | 2 | HP_0002373 | |
| Disease | Neurodevelopmental Disorders | 3.91e-04 | 93 | 45 | 3 | C1535926 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 4.25e-04 | 20 | 45 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | chronic myeloid leukemia (is_marker_for) | 7.79e-04 | 27 | 45 | 2 | DOID:8552 (is_marker_for) | |
| Disease | Vertigo | 1.26e-03 | 139 | 45 | 3 | HP_0002321 | |
| Disease | respiratory system disease | 1.42e-03 | 145 | 45 | 3 | EFO_0000684 | |
| Disease | Parkinson disease | 1.44e-03 | 321 | 45 | 4 | MONDO_0005180 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERSHHSPSERSHHSP | 1731 | Q68DN1 | |
| SHHSPSERRHHSPSE | 1741 | Q68DN1 | |
| LTSAEDRHRHGPHAH | 361 | Q96Q91 | |
| HYFRPHETHHSPSRR | 2721 | Q9NR48 | |
| HQSHHHSEARNHGRA | 76 | Q8NEC5 | |
| FSIRHRSLHRHSHGP | 1281 | P12821 | |
| NTPSHHRVHHGRNRY | 216 | Q6ZNB7 | |
| EQSRDGSRHPRSHHE | 651 | P20930 | |
| GSRHPRSHHEDRAGH | 656 | P20930 | |
| EQSRHGSRHPRSHHE | 976 | P20930 | |
| GSRHPRSHHEDRAGH | 981 | P20930 | |
| RNPRSHQEDRASHGH | 1631 | P20930 | |
| RDGSRHPRSHHEDRA | 2276 | P20930 | |
| HPRSHHEDRAGHGHS | 2281 | P20930 | |
| GSRHPRSHQEDRAGH | 2926 | P20930 | |
| QSRHGSRHPRSHHED | 3246 | P20930 | |
| SRHPRSHHEDRAGHG | 3251 | P20930 | |
| SRDGSRHPTSHHEDR | 3571 | P20930 | |
| RHPTSHHEDRAGHGH | 3576 | P20930 | |
| RARSDPTHQHRHSGG | 526 | Q13627 | |
| RSHSESPRRHHNHGS | 431 | Q9UK58 | |
| PPSTLHGRSHHSHQR | 406 | Q8N7E2 | |
| RSHSDHRSHSDHRLH | 1626 | O14646 | |
| HRSHSDHRLHSDHRS | 1631 | O14646 | |
| RSHGNDHHSKEHQRS | 196 | Q9UHB7 | |
| QRHAEHHARREHDSG | 911 | Q9HCE9 | |
| RDSHRHREASHRDSH | 341 | Q9H0G5 | |
| PSRHQTHGSHLRLHQ | 2671 | P98160 | |
| PERPRHHHHDSDSNS | 221 | Q9BU76 | |
| DSEVHSGGSHRPHSR | 1581 | Q5D862 | |
| PGRHASAKEHRHGDH | 3636 | Q9UPA5 | |
| HPESSSRHTDGHRHG | 846 | Q86XP3 | |
| LSHHQTRPDRTHRQH | 736 | Q7Z3B3 | |
| HHRSPGRSQHSNHRP | 931 | O15083 | |
| RSRLEAPAHAHSHPH | 81 | Q8TB68 | |
| TRHHDASRSPVDHRT | 991 | Q86UR5 | |
| HHGEENHRPSVDHTQ | 1126 | Q5VYJ5 | |
| DHELRHRRHHHQSPK | 26 | Q8TAX7 | |
| RREEHSGRNGLHHPS | 36 | Q16394 | |
| SHRHRPDSLHDAAQR | 96 | P57796 | |
| ERRGHLRPSFHGHHE | 26 | P55287 | |
| SRLPHHSESRQEHER | 491 | Q8N4S9 | |
| RHHRSHRHRPQSSDC | 81 | Q5T753 | |
| HHHHRRRRHREYEHG | 81 | Q3B7T3 | |
| SHHHRTRDPRDNGSR | 566 | Q86X29 | |
| HRHRDHSHGRGERHR | 231 | Q9NRR4 | |
| VTRHFSHAARHGERP | 16 | Q6IN84 | |
| EAHSDHSHRHRGASS | 236 | Q6P5W5 | |
| HGHGRDHHRSHSPLL | 781 | Q6AI14 | |
| DGHHHRDPSHRHRSH | 286 | P23327 | |
| SQGSHLAAHRRDHAP | 441 | Q9BWE0 | |
| GRRESGAPHRRHEHS | 401 | Q92738 | |
| SHRTEHQRTHTGERP | 296 | Q6ZN11 | |
| ARQLHASHAPDHTRH | 501 | P21580 | |
| HRHRHHRCPSRSQSS | 181 | A7MD48 | |
| RSRSKSPGHHRSHRH | 276 | Q8NAV1 | |
| SPGHHRSHRHRSHSK | 281 | Q8NAV1 | |
| HHHPDRRYSRSTQEH | 761 | Q9UGU0 | |
| GHHPRERNHRCSPDH | 201 | Q8WU68 | |
| DESHPHASPSVNRHH | 171 | Q6ZSB9 | |
| HFSAHRRIHTGERPH | 776 | Q8IWY8 | |
| HSRHNSPSGHLTHSR | 731 | Q8IWB9 | |
| SHFHTHQRVHTGERP | 696 | Q14590 | |
| GTRHSHPSVGRQHHA | 291 | O14746 | |
| HDHERTSQSHDRRHE | 401 | Q5T200 |